Common Anti-depressant may Help to Treat Motor Neurone Disease

by VR Sreeraman on November 4, 2008 at 1:20 PM
 Common Anti-depressant may Help to Treat Motor Neurone Disease

Scientists from King's College London have launched a major clinical trial to test whether common antidepressant drug lithium can effectively treat motor neurone disease.

Till now, there is no effective cure or treatment for the fatal motor neuron disease, which is commonly found in men and most likely to strike between the ages of 50 and 70.


However, it can affect any adult at any age.

An Italian study had shown that lithium might have a protective effect with MND, but the British scientists said that the findings should be treated with caution.

The researchers said that the study was necessary because positive findings from a small-scale Italian study were "too dramatic too ignore".

They warn that some side effects of lithium are potentially dangerous.

The director of the MND Care and Research Centre at King's College London, Professor Nigel Leigh, said that the patients were asking him every day whether they should be trying lithium, but that only a "tiny minority" were taking it.

"I'm a bit surprised. I thought more would do it," the BBC quoted Leigh as saying.

"I think it's because everybody's discussing this openly on online sites and there's a very balanced discussion, and people are aware that there are side-effects."

Leigh stressed that GPs and patients with MND should wait for the results before taking Lithium.

"We've been here many times before, with drugs that have been promoted as being a fantastic answer. You don't always get the answer you expected," Leigh said.

The 18-month study involving 220 patients who have had MND for between six months and three years will start at 10 centres across the UK.

Source: ANI
Font : A-A+



Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Common Anti-depressant may Help to Treat Motor Neurone Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests